Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » UF heads to Clinical Oncology Society of Australia Annual Conference

UF heads to Clinical Oncology Society of Australia Annual Conference

  • October 6, 2015
The Unicorn Foundation is proud and excited to announce that we have three abstracts and a oral presentation accepted for the annual Clinical Oncology Society of Australia (COSA) Scientific meeting to be held in Hobart in November 2015.

The abstracts and presentation are focussed on the Oceania data from the INCA/Novartis global NET patient survey combined with local data. The theme of the conference is “Rare Cancers” and it is impressive that the Unicorn Foundation has the opportunity to have such a presence at this event. Dr John Leyden has been involved in all facets of the global survey and with local NET experts – A/Prof Nick Pavlakis, A/Prof Time Price, Prof Stephen Clarke, A/Prof  Michael Michael, Dr Mustafa Khasraw will be able to present the data about the experiences of having a neuroendocrine cancer. We hope that through these abstracts and presentation we can highlight many of the issues and problems that our Australian NET patients face on a daily basis and motivate others in the Australian oncology community to help us make positive changes to improve the outcomes for all our patients.
The Unicorn Foundation will also present on the NET patient perspective within the NET session on Tuesday November 17, "Caught in the NETs".

Posters
“Neuroendocrine tumour (NET) Oceania patient experience: results from the first global NET patient survey – A collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis” – ORAL PRESENTATION
 
"Experience of Australia and New Zealand (ANZ) patients with neuroendocrine tumours (NET) treated at a NET specialist centre: Results of a national survey and the Royal North Shore experience" – POSTER
 
“NET Care in Australia; The patient’s perspective of their Neuroendocrine Tumours (NET) and impact of diagnosis” – POSTER
 
“Symptom burden of Australia and New Zealand (ANZ) patients with Neuroendocrine Tumours (NET)” – POSTER

Share this post

Recent posts

Be the Voice for NET Patients in WA – Join Our CAG Team

June 10, 2025

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousRaising awareness in Canberra
NextUnicorn Foundation Speaks at Senate InquiryNext

Related Posts

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

ANZSNM 55th annual conference in Melbourne – Australia

Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group

NECA Strategy Day 2025

On Wednesday 21 May, NeuroEndocrine Cancer Australia (NECA) hosted our annual Strategy Day in Sydney. It’s the one day each year when our entire team

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin